Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-cash Items: 2016-2024

Historic Non-cash Items for Collegium Pharmaceutical (COLL) over the last 9 years, with Dec 2024 value amounting to $7.0 million.

  • Collegium Pharmaceutical's Non-cash Items rose 22.31% to $66.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $66.2 million, marking a year-over-year increase of 22.31%. This contributed to the annual value of $7.0 million for FY2024, which is 508.27% up from last year.
  • Per Collegium Pharmaceutical's latest filing, its Non-cash Items stood at $7.0 million for FY2024, which was up 508.27% from $1.2 million recorded in FY2023.
  • Collegium Pharmaceutical's 5-year Non-cash Items high stood at $13.0 million for FY2020, and its period low was $1.2 million during FY2023.
  • Over the past 3 years, Collegium Pharmaceutical's median Non-cash Items value was $7.0 million (recorded in 2024), while the average stood at $5.4 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Non-cash Items soared by 521.13% in 2020 and then plummeted by 85.44% in 2023.
  • Collegium Pharmaceutical's Non-cash Items (MRY) stood at $13.0 million in 2020, then tumbled by 82.93% to $2.2 million in 2021, then soared by 258.10% to $8.0 million in 2022, then plummeted by 85.44% to $1.2 million in 2023, then skyrocketed by 508.27% to $7.0 million in 2024.
  • Its Non-cash Items stands at $7.0 million for FY2024, versus $1.2 million for FY2023 and $8.0 million for FY2022.